Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer

S Li, Q Zhang, L Zhou, Y Guan, S Chen, Y Zhang… - Biomedicine & …, 2017 - Elsevier
Breast cancer is one of the most serious malignant tumors that harm to women's health.
Vasculogenic mimicry (VM) is an alternative type of blood supplement independent of …

The role of sema4D in vasculogenic mimicry formation in non‐small cell lung cancer and the underlying mechanisms

Y Xia, XY Cai, JQ Fan, LL Zhang… - … journal of cancer, 2019 - Wiley Online Library
Vasculogenic mimicry (VM) is a special vascular pattern in malignant tumors, which is
composed of highly aggressive tumor cells. This tumor cell‐mediated blood supply pattern is …

[HTML][HTML] ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells

EM Langer, ND Kendsersky, CJ Daniel, GM Kuziel… - Oncogene, 2018 - nature.com
During normal tumor growth and in response to some therapies, tumor cells experience
acute or chronic deprivation of nutrients and oxygen and induce tumor vascularization …

Vasculogenic mimicry and tumor angiogenesis

R Folberg, MJC Hendrix, AJ Maniotis - The American journal of pathology, 2000 - Elsevier
Tumors require a blood supply for growth and hematogenous dissemination. Much attention
has been focused on the role of angiogenesis—the recruitment of new vessels into a tumor …

Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma

M Li, Y Gu, Z Zhang, S Zhang, D Zhang… - Pathology & Oncology …, 2010 - Springer
Vasculogenic mimicry (VM) has been generally recognized as a new pattern of tumor
neovascularization. It presents in many human malignancies. Till now, there is no report …

Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry

AR Hess, EA Seftor, REB Seftor, MJC Hendrix - Cancer research, 2003 - AACR
Vasculogenic mimicry (VM) describes the unique ability of highly aggressive melanoma
tumor cells to express endothelial cell-associated genes (such as EphA2 and VE-cadherin) …

[HTML][HTML] Gene-expression profiling of microdissected breast cancer microvasculature identifies distinct tumor vascular subtypes

F Pepin, N Bertos, J Laferrière, S Sadekova… - Breast Cancer …, 2012 - Springer
Introduction Angiogenesis represents a potential therapeutic target in breast cancer.
However, responses to targeted antiangiogenic therapies have been reported to vary …

[HTML][HTML] Platelets disrupt vasculogenic mimicry by cancer cells

C Martini, EJ Thompson, SR Hyslop, MP Cockshell… - Scientific reports, 2020 - nature.com
Tumour vasculature supports the growth and progression of solid cancers with both
angiogenesis (endothelial cell proliferation) and vasculogenic mimicry (VM, the formation of …

[HTML][HTML] Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma

HS Kim, YJ Won, JH Shim, HJ Kim, J Kim, HN Hong… - Scientific reports, 2019 - nature.com
Genetically deregulated tumor cells generate vascular channels by vasculogenic mimicry
(VM) that is independent of endothelial blood vessels. The morphological characteristics of …

[HTML][HTML] Peroxisome proliferator-activated receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway

L Qin, Y Ren, AM Chen, FJ Guo… - Molecular …, 2014 - spandidos-publications.com
Vasculogenic mimicry (VM) describes functional vascular channels composed only of tumor
cells and its presence predicts a poor prognosis for patients with prostate cancer. The …